Two more firms contact Drap for vaccine registration

Published January 22, 2021
Two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines. — AFP/File
Two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines. — AFP/File

ISLAMABAD: While three foreign pharmaceutical companies have already developed their stakes in Pakistan, two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines.

On Thursday, 2,363 new cases and 54 deaths were reported due to coronavirus in a single day as the number of active cases reached 35,293 across the country.

An official of the Ministry of National Health Services (NHS) said that Russia’s state-owned Sputnik-V company has filed an application seeking permission for emergency use of its vaccine in Pakistan.

“It is a double-dose vaccine and will be administered by syringes,” he said.

“Moreover, Chinese firm Anhui Zheifi Longcom Biopharmaceuticals Company Limited has applied for phase-III clinical trial of its vaccine in Pakistan. The vaccine has been jointly developed by the company and the Institute of Microbiology under the Chinese Academy of Sciences,” the official said.

Earlier, three firms had developed their interests in Pakistan as British firm Oxford-AstraZeneca and Chinese firm Sinopharm’s vaccines were registered with Drap. The third firm namely CanSino Biologics is also a Chinese firm and it has been conducting phase-III clinical trial of its vaccine in Pakistan.

54 die of Covid-19 in a single day in Pakistan

“Oxford-AstraZeneca’s vaccine will be received through the international alliance Covax and also through a private channel. Pakistan has pre-booked 1.1 million doses of Sinopharm’s vaccine,” the official said.

Meanwhile, Usman Ghani, a representative of Sindh Medical Store which has got Oxford-AstraZeneca vaccine registered with Drap, said the manufacturer had not given any timeline for supplying the vaccine because of priorities set by the Indian government for local preferences.

According to data of the National Command and Operation Centre, as many as 2,363 people were infected with coronavirus and 54 died due to Covid-19 in a single day. While there were 324 ventilators in use of Covid-19 patients, Multan’s 49 per cent, Islamabad’s 40pc, Lahore’s 37pc and Peshawar’s 30pc vents were in use.

Published in Dawn, January 22nd, 2021

Opinion

Editorial

The establishment pivot
18 Jan, 2022

The establishment pivot

It is a sad reality that the power matrix continues to revolve around the establishment.
18 Jan, 2022

Remittances growth

THE hefty growth in remittances from Pakistanis living abroad continues to defy forecasts to the contrary. New State...
18 Jan, 2022

China-Iran deal

THE China-Iran strategic deal that has recently taken effect is more than just a long-term bilateral agreement...
Security policy unveiled
Updated 17 Jan, 2022

Security policy unveiled

PAKISTAN’S freshly unveiled National Security Policy has broadened the traditional concept and included economic...
Bold decisions
Updated 17 Jan, 2022

Bold decisions

IT is a double blow within a matter of days. The Islamabad High Court’s order last week to demolish a navy golf...
17 Jan, 2022

Rohingya camp blaze

A HUGE blaze in a refugee camp housing members of the Rohingya community in Bangladesh last week has left up to ...